Pegasus Biotech Inc. has recently revealed a significant partnership with the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) aimed at accelerating the progress and market release of Pegasus's BPE DNA platform for advanced biologics. This collaboration marks a pivotal step in the development of next-generation biologics.